70 related articles for article (PubMed ID: 20199151)
1. A Competitive ELISA for quantifying serum CD147: reduction of soluble CD147 levels in cancer patient sera.
Moonsom S; Tayapiwatana C; Wongkham S; Kongtawelert P; Kasinrerk W
Hybridoma (Larchmt); 2010 Feb; 29(1):45-52. PubMed ID: 20199151
[TBL] [Abstract][Full Text] [Related]
2. Oxidized low-density lipoprotein-induced CD147 expression and its inhibition by high-density lipoprotein on platelets in vitro.
Yang SH; Li YT; Du DY
Thromb Res; 2013; 132(6):702-11. PubMed ID: 24144446
[TBL] [Abstract][Full Text] [Related]
3. Expression and clinical significance of CD147 in genitourinary carcinomas.
Han ZD; He HC; Bi XC; Qin WJ; Dai QS; Zou J; Ye YK; Liang YX; Zeng GH; Zhu G; Chen ZN; Zhong WD
J Surg Res; 2010 May; 160(2):260-7. PubMed ID: 19286191
[TBL] [Abstract][Full Text] [Related]
4. Evaluating Soluble EMMPRIN as a Marker of Disease Activity in Multiple Sclerosis: Studies of Serum and Cerebrospinal Fluid.
Kaushik DK; Yong HY; Hahn JN; Silva C; Casha S; Hurlbert RJ; Jacques FH; Lisak R; Khan O; Ionete C; Larochelle C; Prat A; Bar-Or A; Yong VW
PLoS One; 2016; 11(10):e0163802. PubMed ID: 27727297
[TBL] [Abstract][Full Text] [Related]
5. Sensitive detection of CD147/EMMPRIN and its expression on cancer cells with electrochemical technique.
Zheng D; Zhu X; Ding X; Zhu X; Yin Y; Li G
Talanta; 2013 Feb; 105():187-91. PubMed ID: 23598007
[TBL] [Abstract][Full Text] [Related]
6. Expression of CD147, BIGH3 and Stathmin and their potential role as diagnostic marker in patients with urothelial carcinoma of the bladder.
Bhagirath D; Abrol N; Khan R; Sharma M; Seth A; Sharma A
Clin Chim Acta; 2012 Oct; 413(19-20):1641-6. PubMed ID: 22626996
[TBL] [Abstract][Full Text] [Related]
7. Treatment of (131)I-labeled anti-CD147 monoclonal antibody in VX2 carcinoma-induced liver tumors.
Niu H; Wang R; Cheng J; Gao S; Liu B
Oncol Rep; 2013 Jul; 30(1):246-52. PubMed ID: 23612800
[TBL] [Abstract][Full Text] [Related]
8. Circulating levels of soluble EMMPRIN (CD147) correlate with levels of soluble glycoprotein VI in human plasma.
Pennings GJ; Yong AS; Wong C; Al-Tamimi M; Gardiner EE; Andrews RK; Kritharides L
Platelets; 2014; 25(8):639-42. PubMed ID: 24245520
[TBL] [Abstract][Full Text] [Related]
9. Association of extracellular matrix metalloproteinase inducer in endometrial carcinoma with patient outcomes and clinicopathogenesis using monoclonal antibody 12C3.
Ueda K; Yamada K; Urashima M; Ishibashi Y; Shirai M; Nikaido T; Takahashi H; Okamoto A; Saito M; Yasuda M; Ohkawa K; Tanaka T
Oncol Rep; 2007 Apr; 17(4):731-5. PubMed ID: 17342307
[TBL] [Abstract][Full Text] [Related]
10. EMMPRIN levels in serum of patients with amyotrophic lateral sclerosis.
Iłżecka J
Acta Neurol Scand; 2011 Dec; 124(6):424-8. PubMed ID: 21554254
[TBL] [Abstract][Full Text] [Related]
11. Silencing CD147 inhibits tumor progression and increases chemosensitivity in murine lymphoid neoplasm P388D1 cells.
Jia L; Wei W; Cao J; Xu H; Miao X; Zhang J
Ann Hematol; 2009 Aug; 88(8):753-60. PubMed ID: 19125248
[TBL] [Abstract][Full Text] [Related]
12. Gingival crevicular fluid matrix metalloproteinase (MMP)-7, extracellular MMP inducer, and tissue inhibitor of MMP-1 levels in periodontal disease.
Emingil G; Tervahartiala T; Mãntylã P; Määttä M; Sorsa T; Atilla G
J Periodontol; 2006 Dec; 77(12):2040-50. PubMed ID: 17209789
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of CD147 gene expression via RNA interference reduces tumor cell invasion, tumorigenicity and increases chemosensitivity to paclitaxel in HO-8910pm cells.
Zou W; Yang H; Hou X; Zhang W; Chen B; Xin X
Cancer Lett; 2007 Apr; 248(2):211-8. PubMed ID: 16930823
[TBL] [Abstract][Full Text] [Related]
14. HAb18G/CD147 functions in invasion and metastasis of hepatocellular carcinoma.
Xu J; Xu HY; Zhang Q; Song F; Jiang JL; Yang XM; Mi L; Wen N; Tian R; Wang L; Yao H; Feng Q; Zhang Y; Xing JL; Zhu P; Chen ZN
Mol Cancer Res; 2007 Jun; 5(6):605-14. PubMed ID: 17579119
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of extracellular matrix metalloproteinase inducer (EMMPRIN/CD147) in avian tibial dyschondroplasia.
Shahzad M; Liu J; Gao J; Wang Z; Zhang D; Nabi F; Li K; Li J
Avian Pathol; 2015; 44(1):13-8. PubMed ID: 25402545
[TBL] [Abstract][Full Text] [Related]
16. Intracoronary upregulation of platelet extracellular matrix metalloproteinase inducer (CD147) in coronary disease.
Yong A; Pennings G; Wong C; Javadzadegan A; Brieger D; Lowe H; Qi M; Behnia M; Krilis S; Kritharides L
Int J Cardiol; 2013 Jul; 166(3):716-21. PubMed ID: 22192282
[TBL] [Abstract][Full Text] [Related]
17. Emmprin (basigin/CD147): matrix metalloproteinase modulator and multifunctional cell recognition molecule that plays a critical role in cancer progression.
Nabeshima K; Iwasaki H; Koga K; Hojo H; Suzumiya J; Kikuchi M
Pathol Int; 2006 Jul; 56(7):359-67. PubMed ID: 16792544
[TBL] [Abstract][Full Text] [Related]
18. Cancer-related issues of CD147.
Weidle UH; Scheuer W; Eggle D; Klostermann S; Stockinger H
Cancer Genomics Proteomics; 2010; 7(3):157-69. PubMed ID: 20551248
[TBL] [Abstract][Full Text] [Related]
19. Epitope mapping of series of monoclonal antibodies against the hepatocellular carcinoma-associated antigen HAb18G/CD147.
Ku XM; Liao CG; Li Y; Yang XM; Yang B; Yao XY; Wang L; Kong LM; Zhao P; Chen ZN
Scand J Immunol; 2007 May; 65(5):435-43. PubMed ID: 17444954
[TBL] [Abstract][Full Text] [Related]
20. Regulation of MMP-1 and MMP-2 production through CD147/extracellular matrix metalloproteinase inducer interactions.
Sun J; Hemler ME
Cancer Res; 2001 Mar; 61(5):2276-81. PubMed ID: 11280798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
